Stéphane De Wit Selected Research

ritonavir drug combination atazanavir

1/2018

Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stéphane De Wit Research Topics

Disease

8	Infections 05/2022 - 06/2013
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 03/2011
5	Neoplasms (Cancer) 03/2022 - 06/2009
3	COVID-19 01/2022 - 07/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2014
3	HIV Infections (HIV Infection) 01/2021 - 01/2014
2	Myocardial Infarction 01/2018 - 06/2015
2	Coinfection 01/2015 - 03/2013
1	Yellow Fever 03/2022
1	Hypersensitivity (Allergy) 12/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2021
1	Tetanus 01/2021
1	Chronic Disease (Chronic Diseases) 11/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018
1	Stroke (Strokes) 01/2018
1	Squamous Intraepithelial Lesions 02/2017
1	Hyponatremia 01/2017
1	Viremia 01/2017
1	Hepatorenal Syndrome 01/2016
1	Hepatic Encephalopathy 01/2016
1	Hemorrhage 01/2016
1	End Stage Liver Disease 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2015
1	Ulcer 06/2015
1	HIV Seropositivity 01/2014
1	Hepatitis B 03/2013
1	Latent Infection 06/2009
1	Neurologic Manifestations (Neurological Manifestations) 03/2007
1	Neurosyphilis (General Paresis of the Insane) 03/2007

Drug/Important Bio-Agent (IBA)

3	IntegrasesIBA 03/2022 - 12/2021
3	Pharmaceutical PreparationsIBA 01/2022 - 03/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2015
2	VaccinesIBA 03/2022 - 01/2021
2	remdesivirIBA 12/2021 - 07/2021
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2016
2	Anti-HIV Agents (AIDS Drugs)IBA 01/2016 - 03/2013
2	prostratinIBA 07/2012 - 06/2009
2	Histone Deacetylase InhibitorsIBA 07/2012 - 06/2009
1	ChromatinIBA 05/2022
1	Integrase InhibitorsIBA 03/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	cilgavimabIBA 01/2022
1	tixagevimabIBA 01/2022
1	cilgavimab and tixagevimab drug combinationIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 12/2021
1	Oxygen (Dioxygen)IBA 12/2021
1	Tenofovir (Viread)FDA Link 01/2021
1	TabletsIBA 01/2021
1	elvitegravirIBA 01/2021
1	Emtricitabine (Emtriva)FDA Link 01/2021
1	Tenofovir Disoproxil Fumarate Drug Combination Emtricitabine Cobicistat ElvitegravirIBA 01/2021
1	CobicistatIBA 01/2021
1	carbapenemaseIBA 11/2020
1	ritonavir drug combination atazanavirIBA 01/2018
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2018
1	Meropenem (Merrem)FDA LinkGeneric 01/2018
1	NucleosidesIBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	Darunavir (Prezista)FDA Link 01/2018
1	Atazanavir Sulfate (Reyataz)FDA Link 01/2018
1	Reverse Transcriptase InhibitorsIBA 01/2018
1	Ritonavir (Norvir)FDA Link 01/2018
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 01/2018
1	BilirubinIBA 01/2018
1	ElectrolytesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Didanosine (Videx)FDA LinkGeneric 01/2016
1	Fetal Proteins (Fetoprotein)IBA 01/2016
1	Stavudine (Zerit)FDA LinkGeneric 01/2016
1	MacrolidesIBA 12/2015
1	Thalidomide (Thalomid)FDA Link 06/2015
1	1,2,3,5,6,7- hexahydro- 7- methyl- 8- (4- tolylsulfinyl)- 5- indolizinoneIBA 07/2012
1	Vorinostat FDA Link 07/2012
1	NF-kappa B (NF-kB)IBA 06/2009
1	ReaginsIBA 03/2007

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2016
4	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 03/2011
4	Art Therapy 01/2021 - 01/2014
1	Carotid Endarterectomy 01/2018
1	Liver Transplantation 01/2016
1	Retention in Care 01/2014